EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2

Zachary J Frangos, Katie A Wilson iD, Heather M Aitken, Ryan Cantwell Chater iD, Robert J Vandenberg iD, Megan L O'Mara iD

Life Science Alliance · 2023-04 · 6 (4) · e202201708

DOI: 10.26508/lsa.202201708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 23.01.2023. Verfasst von Zachary J Frangos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biomedicine Theme, School of Medical Sciences, University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Glycine Plasma Membrane Transport Proteins, Glycine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, DHAC | National Health and Medical Research Council, Australian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Membrane cholesterol binds to and modulates the function of various SLC6 neurotransmitter transporters, including stabilizing the outward-facing conformation of the dopamine and serotonin transporters. Here, we investigate how cholesterol binds to GlyT2 (SLC6A5), modulates glycine transport rate, and influences bioactive lipid inhibition of GlyT2. Bioactive lipid inhibitors are analgesics that bind to an allosteric site accessible from the extracellular solution when GlyT2 adopts an outward-facing conformation. Using molecular dynamics simulations, mutagenesis, and cholesterol depletion experiments, we show that bioactive lipid inhibition of glycine transport is modulated by the recruitment of membrane cholesterol to a binding site formed by transmembrane helices 1, 5, and 7. Recruitment involves cholesterol flipping from its membrane orientation, and insertion of the 3′ hydroxyl group into the cholesterol binding cavity, close to the allosteric site. The synergy between cholesterol and allosteric inhibitors provides a novel mechanism of inhibition and a potential avenue for the development of potent GlyT2 inhibitors as alternative therapeutics for the treatment of neuropathic pain and therapeutics that target other SLC6 transporters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycine Plasma Membrane Transport ProteinsGlycineIon TransportCholesterolLipids

Substanzen

Glycine Plasma Membrane Transport ProteinsGlycineCholesterolLipids

Autor:innen und Institutionen

  • Molecular Biomedicine Theme, School of Medical Sciences, University of Sydney, Sydney, Australia.
  • Research School of Chemistry, College of Science, The Australian National University, Canberra, Australia.
  • Department of Biochemistry, Memorial University of Newfoundland, St. John's, Canada.
  • Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Australia.
  • Research School of Chemistry, College of Science, The Australian National University, Canberra, Australia m.omara@uq.edu.au.

ORCID-Profile: Katie A Wilson, Ryan Cantwell Chater, Robert J Vandenberg, Megan L O'Mara

Förderung

  • NIDA NIH HHS
  • DHAC | National Health and Medical Research Council
  • Australian Government

Zitieren

APA

Frangos, Z. J., Wilson, K. A., Aitken, H. M., Cantwell Chater, R., Vandenberg, R. J., & O'Mara, M. L. (2023). Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2. Life Science Alliance, 6(4), e202201708. https://doi.org/10.26508/lsa.202201708

Vancouver

Frangos ZJ, Wilson KA, Aitken HM, Cantwell Chater R, Vandenberg RJ, O'Mara ML. Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2. Life Science Alliance. 2023;6(4):e202201708. doi:10.26508/lsa.202201708

BibTeX
@article{Frangos2023,
  author = {Frangos, Zachary J and Wilson, Katie A and Aitken, Heather M and Cantwell Chater, Ryan and Vandenberg, Robert J and O'Mara, Megan L},
  title = {Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2},
  journal = {Life Science Alliance},
  year = {2023},
  volume = {6},
  number = {4},
  pages = {e202201708},
  doi = {10.26508/lsa.202201708}
}
Kostenlos starten →